Medicenna Therapeutics annual r&d spending
2020
2021
2022
2023
2024
2025
2026
Medicenna Therapeutics R&D Spending Growth & History (MDNAF)
Medicenna Therapeutics's r&d spending was $16.9M for fiscal 2026.
View full Medicenna Therapeutics company overviewMedicenna Therapeutics annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | $16.9M | $2.4M | +16.89% |
| 2025 | 2025-03-31 | $14.4M | $3.6M | +33.74% |
| 2024 | 2024-03-31 | $10.8M | $1.5M | +16.08% |
| 2023 | 2023-03-31 | $9.3M | −$5.4M | −36.78% |
| 2022 | 2022-03-31 | $14.7M | $3.8M | +35.38% |
| 2021 | 2021-03-31 | $10.9M | $5.0M | +85.18% |
| 2020 | 2020-03-31 | $5.9M | — | — |
Medicenna Therapeutics quarterly r&d spending
Q4.25
Q1.26
Q2.26
Q3.26
Q4.26
Q1.27
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-06-30 | $4.2M | $38,000 | +0.90% |
| Q4 2026 | 2026-03-31 | $4.5M | $3,000 | +0.07% |
| Q3 2026 | 2025-12-31 | $4.1M | — | — |
| Q2 2026 | 2025-09-30 | $4.1M | — | — |
| Q1 2026 | 2025-06-30 | $4.2M | — | — |
| Q4 2025 | 2025-03-31 | $4.5M | — | — |
Medicenna Therapeutics r&d spending trends
Over the last five fiscal years, Medicenna Therapeutics's r&d spending increased from $10.9M to $16.9M, a change of $6.0M. The latest reported quarter, Q1 2027, shows $4.2M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Medicenna Therapeutics source filings ↗